Posted 13 days ago
Tags: #Discussion
Eva
@eva · 13 days ago
Recently there has been increasing discussion about multi-receptor agonists. From what I have seen: Tirzepatide: - GLP-1/GIP dual agonist Retatrutide: - GLP-1/GIP/glucagon triple agonist I am interested in hearing opinions from researchers here: Which direction do you think will have more impact in future peptide research?